Pharmaceutical composition comprising a hmg-coa reductase...

Details Pharmaceutical composition comprising a hmg-coa reductase... Pharmaceutical composition comprising a hmg-coa reductase...

2005-06-28

2005-06-28

Henley, III, Raymond J. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S345000, C514S419000, C514S423000, C514S460000

Reexamination Certificate

active

06911472

ABSTRACT:
A pharmaceutical composition comprising as an active ingredient an HMG-CoA reductase inhibitor and an aminosugar.

REFERENCES:
patent: 5030447 (1991-07-01), Joshi et al.
patent: 5356896 (1994-10-01), Kabadi et al.
patent: 6551617 (2003-04-01), Corbo et al.
patent: 6680341 (2004-01-01), Kerc
patent: 0 547 000 (1982-06-01), None
patent: 94/16693 (1994-08-01), None
patent: 00/35425 (2000-06-01), None
patent: 01/93860 (2001-12-01), None
The American Heritage Dictionary, Second College Edition, published 1982 by Houghton Miffin Co., p. 805 “mix”.
* Kibbe Ah: “Handbook of Pharmaceutical Excipients”, American Pharmaceutical Association, Washington, DC, USA, pp. 332-333 (2000).

Affiliated with

Also associated with

Rating

Pharmaceutical composition comprising a hmg-coa reductase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising a hmg-coa reductase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising a hmg-coa reductase... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3467916